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Introduction
Cytokines such as IL1 are central mediators of joint
inflammation in patients with rheumatoid arthritis (RA)
and ankylosing spondylitis (AS) and polymorphism in
IL1 has been associated with disease susceptibility and
severity.
Aim
To evaluate the role of the polymorphism rs1143634 in
the IL1B gene in the pharmacogenetic of RA and AS
patients treated with infliximab.
Patients and methods
IL1B genotyping was performed in a subset of 42 RA
and 39 AS patients treated with infliximab. Response
was assessed at the 3
rd and 6
th month of treatment by
EULAR for RA and BASDAI criteria for AS.
Results
According to the EULAR criteria no significant associa-
tions were found between IL1B genotypes and response
in RA patients. Distribution of IL1B rs1143634 genotype
revealed a significant association in AS between the
T allele with better response (responders: T 93.5%,
C 60.4% vs. non responders: T 6.7%, C 39.6%; p=0.007)
and between TT+TC genotypes and better response
(CC 52.4% vs. 92.3% TT+TC; p=0.009) at 3 months
after treatment commencement according to BASDAI
criteria.
Conclusions
rs1143634 seems to influence the response to infliximab
treatment in AS but not in AR patients though this find-
ing must be confirmed in a study with larger sample size.
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